×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ORGO – organogenesis holdings inc. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ORGO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
09:32 am
orgo
Organogenesis Commends Final LCDs [Yahoo! Finance]
Medium
Report
Organogenesis Commends Final LCDs [Yahoo! Finance]
11/15
09:25 am
orgo
Organogenesis Commends Final LCDs
Medium
Report
Organogenesis Commends Final LCDs
11/13
02:32 am
orgo
Organogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
High
Report
Organogenesis Holdings Inc (ORGO) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... [Yahoo! Finance]
11/12
09:56 pm
orgo
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
High
Report
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript [Yahoo! Finance]
11/12
04:05 pm
orgo
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
High
Report
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results
11/12
04:01 pm
orgo
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
High
Report
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock
11/11
05:09 pm
orgo
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis [Yahoo! Finance]
Low
Report
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis [Yahoo! Finance]
11/11
05:05 pm
orgo
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
Low
Report
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:05 pm
orgo
organogenesis holdings inc. - class a
BEAT
Report
28.4%
organogenesis holdings inc. - class a
8/8/2024
04:05 pm
orgo
organogenesis holdings inc. - class a
MISS
Report
-2.7%
organogenesis holdings inc. - class a
5/9/2024
04:05 pm
orgo
organogenesis holdings inc. - class a
BEAT
Report
32.9%
organogenesis holdings inc. - class a
2/29/2024
04:05 pm
orgo
organogenesis holdings inc. - class a
BEAT
Report
-18.2%
organogenesis holdings inc. - class a
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/19
04:06 pm
orgo
Form SC 13D Organogenesis Holdings Filed by: Avista Healthcare Partners III, L.P.
Low
Report
Form SC 13D Organogenesis Holdings Filed by: Avista Healthcare Partners III, L.P.
11/19
04:05 pm
orgo
Form 3 Organogenesis Holdings For: Nov 12 Filed by: Avista Capital Partners VI GP, L.P.
Low
Report
Form 3 Organogenesis Holdings For: Nov 12 Filed by: Avista Capital Partners VI GP, L.P.
11/14
08:10 pm
orgo
Form SC 13D/A Organogenesis Holdings Filed by: Ades Alan A.
Low
Report
Form SC 13D/A Organogenesis Holdings Filed by: Ades Alan A.
11/14
07:28 pm
orgo
Form 4 Organogenesis Holdings For: Nov 12 Filed by: Organo PFG LLC
Low
Report
Form 4 Organogenesis Holdings For: Nov 12 Filed by: Organo PFG LLC
11/14
07:28 pm
orgo
Form 3 Organogenesis Holdings For: Nov 12 Filed by: Lustig Garrett
Low
Report
Form 3 Organogenesis Holdings For: Nov 12 Filed by: Lustig Garrett
11/14
07:28 pm
orgo
Form 4 Organogenesis Holdings For: Nov 12 Filed by: Erani Dennis
Low
Report
Form 4 Organogenesis Holdings For: Nov 12 Filed by: Erani Dennis
11/14
03:36 pm
orgo
Form SC 13G/A Organogenesis Holdings Filed by: Soleus Capital Master Fund, L.P.
Low
Report
Form SC 13G/A Organogenesis Holdings Filed by: Soleus Capital Master Fund, L.P.
11/13
09:29 am
orgo
Form 8-K Organogenesis Holdings For: Nov 12
High
Report
Form 8-K Organogenesis Holdings For: Nov 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/12
Organogenesis Holdings Inc (NASDAQ: ORGO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $3.25 price target on the stock.
33.2%
8/16 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 29.1%
3/16 Form 4 Organogenesis Holdings For: Mar 12 Filed by: Burgstahler David F 18.4%
9/5 Form 4 Organogenesis Holdings For: Sep 03 Filed by: Dean Thompson 15.1%
9/20 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 14.7%
4/16 Form 4 Organogenesis Holdings For: Oct 01 Filed by: Grow Brian 12.2%
9/10 Form 4 Organogenesis Holdings For: Sep 06 Filed by: GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 11.5%
11/12 Organogenesis Holdings Inc (ORGO) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.6%
8/31 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 7.8%
4/24 Form 4 Organogenesis Holdings For: Apr 22 Filed by: Leibowitz Arthur S 7.7%
8/16 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 29.1%
3/16 Form 4 Organogenesis Holdings For: Mar 12 Filed by: Burgstahler David F 18.4%
9/5 Form 4 Organogenesis Holdings For: Sep 03 Filed by: Dean Thompson 15.1%
9/20 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 14.7%
4/16 Form 4 Organogenesis Holdings For: Oct 01 Filed by: Grow Brian 12.2%
9/10 Form 4 Organogenesis Holdings For: Sep 06 Filed by: GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 11.5%
11/12 Organogenesis Holdings Inc (ORGO) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.6%
8/31 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 7.8%
4/24 Form 4 Organogenesis Holdings For: Apr 22 Filed by: Leibowitz Arthur S 7.7%
TOP News Decliners
11/21
Organogenesis Holdings Inc. Announces Pricing of Public Offering of Class A Common Stock
-22.2%
3/18 Organogenesis Holdings Inc (NASDAQ: ORGO) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -18.9%
3/9 Form 10-K Organogenesis Holdings For: Dec 31 -18.3%
8/19 Organogenesis Announces Completion of Exchange Offer and Plan to Exchange Remaining Outstanding Public Warrants -14.8%
4/1 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -12.0%
7/12 Form PRE 14A Organogenesis Holdings For: Jul 12 -11.9%
9/9 Form SC 13D/A Organogenesis Holdings Filed by: Avista Acquisition Corp. -8.5%
3/16 Form 8-K Organogenesis Holdings For: Mar 10 -8.2%
7/22 Organogenesis Holdings Commences Offer to Exchange Class A Common Stock for any and all Outstanding Public Warrants and Consent Solicitation -7.8%
7/16 Form SC TO-C Organogenesis Holdings Filed by: Organogenesis Holdings Inc. -7.6%
3/18 Organogenesis Holdings Inc (NASDAQ: ORGO) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -18.9%
3/9 Form 10-K Organogenesis Holdings For: Dec 31 -18.3%
8/19 Organogenesis Announces Completion of Exchange Offer and Plan to Exchange Remaining Outstanding Public Warrants -14.8%
4/1 Organogenesis Holdings Inc (NASDAQ: ORGO) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. -12.0%
7/12 Form PRE 14A Organogenesis Holdings For: Jul 12 -11.9%
9/9 Form SC 13D/A Organogenesis Holdings Filed by: Avista Acquisition Corp. -8.5%
3/16 Form 8-K Organogenesis Holdings For: Mar 10 -8.2%
7/22 Organogenesis Holdings Commences Offer to Exchange Class A Common Stock for any and all Outstanding Public Warrants and Consent Solicitation -7.8%
7/16 Form SC TO-C Organogenesis Holdings Filed by: Organogenesis Holdings Inc. -7.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: